K. Birgitta Whaley

K. Birgitta Whaley's AcademicInfluence.com Rankings

K. Birgitta Whaley

Chemistry

#2324

World Rank

#3215

Historical Rank

chemistry Degrees

Download Badge

Chemistry

K. Birgitta Whaley's Degrees

PhD Chemistry University of California, Berkeley
Bachelors Chemistry University of California, Berkeley

Why Is K. Birgitta Whaley Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Katherine Birgitta Whaley is a professor of chemistry at the University of California Berkeley and a senior faculty scientist in the Division of Chemical Sciences at Lawrence Berkeley National Laboratory. At UC Berkeley, Whaley is the director of the Berkeley Quantum Information and Computation Center, a member of the executive board for the Center for Quantum Coherent Science, and a member of the Kavli Energy Nanosciences Institute. At Lawrence Berkeley National Laboratory, Whaley is a member of the Quantum Algorithms Team for Chemical Sciences in the research area of resource-efficient algorithms.

(See a Problem?)

K. Birgitta Whaley's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Modulation of the alternative complement pathways by beta 1 H globulin (1976) (496)
Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes (1980) (342)
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. (1976) (177)
Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils. (1997) (159)
Modulation of C3b hemolytic activity by a plasma protein distinct from C3b inactivator. (1976) (139)
MODULATION OF THE ALTERNATIVE COMPLEMENT PATHWAY BY fllH GLOBULIN (1976) (138)
Sjogren's syndrome. 2. Clinical associations and immunological phenomena. (1973) (135)
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. (1975) (98)
Liver disease in Sjögren's syndrome and rheumatoid arthritis. (1970) (92)
Endotoxaemia and complement activation in acute pancreatitis in man. (1982) (88)
Histology of the lacrimal gland in keratoconjunctivitis sicca. (1973) (81)
Sjøgren's SyndromeI. SICCA COMPONENTS (1973) (80)
Effect of interferon-gamma on complement gene expression in different cell types. (1992) (77)
Complement and complement deficiencies. (1997) (76)
Sjögren's syndrome and autoimmunity in a geriatric population. (1972) (75)
Otolaryngological Aspects of Sjögren's Syndrome (1971) (74)
Synthesis of classical pathway complement components by chondrocytes. (1996) (69)
Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis. (1980) (66)
Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. (1975) (63)
Autoantibody facilitated cleavage of C1-inhibitor in autoimmune angioedema. (1989) (59)
Complement-subcomponent-C1-inhibitor synthesis by human monocytes. (1985) (55)
A statistical aid to the diagnosis of keratoconjunctivitis sicca. (1972) (54)
Sjogren's syndrome. I. Sicca components. (1973) (54)
Modulation of monocyte complement synthesis by interferons. (1987) (51)
Expression of the components and regulatory proteins of the alternative complement pathway and the membrane attack complex in normal and diseased synovium (2004) (48)
Interferon-induced transcriptional and post-transcriptional modulation of factor H and C4 binding-protein synthesis in human monocytes. (1990) (46)
Complement biosynthesis by mononuclear phagocytes (1993) (46)
Adrenergic receptors on monocytes modulate complement component synthesis. (1982) (45)
Epitope mapping of C1 inhibitor autoantibodies from patients with acquired C1 inhibitor deficiency. (1996) (45)
Adenosine A2 receptors on human monocytes modulate C2 production. (1984) (45)
Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus. (1986) (44)
Regulation of the synthesis of C1 subcomponents and C1-inhibitor. (1993) (43)
Precipitating antibodies to cellular antigens in Sjögren's syndrome, rheumatoid arthritis, and other organ and nonorgan-specific autoimmune diseases. (1978) (43)
Salivary duct autoantibody in Sjøgren's syndrome: correlation with focal sialadenitis in the labial mucosa (1969) (40)
An examination of the immunology of cancer patients (1976) (39)
Human complement factor H. Tissue specificity in the expression of three different mRNA species. (1991) (39)
Modulation by interferons of the expression of monocyte complement genes. (1990) (39)
Measurement of joint inflammation. A radioisotopic method. (1970) (39)
C2 synthesis by human monocytes is modulated by a nicotinic cholinergic receptor (1981) (37)
Methods in complement for clinical immunologists (1985) (36)
Decreased Total Numbers of Peripheral Blood Lymphocytes with Elevated Percentages of CD4+CD45RO+ and CD4+CD25+ of T‐Helper Cells in Non‐Segmental Vitiligo (2002) (36)
The articular scan in patients with rheumatoid arthritis: a possible method of quantitating joint inflammation using radio-technetium. (1968) (35)
Hydrostatic Sialography as an Index of Salivary Gland Disease in Sjögren's Syndrome (1971) (34)
Modulation of complement gene expression by glucocorticoids. (1991) (34)
Interferon-mediated transcriptional and post-transcriptional modulation of complement gene expression in human monocytes. (1990) (33)
Clinical studies on inflammation in human knee joints: xenon (133Xe) clearances correlated with clinical assessment in various arthritides and studies on the effect of intra-articularly administered hydrocortisone in rheumatoid arthritis. (1970) (33)
Thymoma‐associated cutaneous graft‐versus‐host‐like reaction (1997) (32)
Complement activation in chronic liver disease. (1982) (32)
Sjögren's Syndrome (1972) (31)
Immunological responses in Sjogren's syndrome and rheumatoid arthritis. (1971) (30)
Complement biosynthesis in human synovial tissue. (1989) (30)
Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum. (1978) (30)
Expression of the components and regulatory proteins of the classical pathway of complement in normal and diseased synovium (2004) (29)
Effects of histamine on monocyte complement production. I. Inhibition of C2 production mediated by its action on H2 receptors. (1980) (29)
C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus. (1987) (28)
C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase. (1976) (26)
Sialographic abnormalities in Sjogren's syndrome, rheumatoid arthritis, and other arthritides and connective tissue diseases. A clinical and radiological investigation using hydrostatic sialography. (1972) (26)
Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. (1970) (26)
Complement-mediated inhibition of immune precipitation in patients with immune complex diseases. (1983) (25)
Diagnostic value of quantitative scintiscanning of the salivary glands in Sjögren's syndrome and rheumatoid arthritis. (1971) (25)
Immune complexes in Sjögren's syndrome. (1980) (25)
Sjögren's syndrome in relation to pernicious anaemia and idiopathic Addison's disease. (1970) (24)
IgM-RF prevents complement-mediated inhibition of immune precipitation. (1984) (24)
Autoimmune C1‐inhibitor deficiency (1996) (24)
Systemic lupus erythematosus complicating hyper IgE syndrome. (1997) (24)
Complement in Health and Disease (2012) (24)
Monocyte C1‐inhibitor synthesis in patients with C1‐inhibitor deficiency (1989) (23)
Studies on the sympathetic control of normal and diseased synovial blood vessels: the effect of alpha and beta receptor stimulation and inhibition, monitored by the 133xenon clearance technique. (1971) (23)
Complement and immune complex diseases. (1986) (22)
Prevention of immune precipitation by purified classical pathway complement components. (1984) (22)
Prostaglandins and prostaglandin synthetase inhibitors regulate the synthesis of complement components by human monocytes. (1982) (22)
Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages. (1986) (21)
Cyclic nucleotides and their relationship to complement-component-C2 synthesis by human monocytes. (1984) (21)
The effects of immunoglobulin isotype and antibody affinity on complement-mediated inhibition of immune precipitation and solubilization. (1987) (21)
Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos. (1973) (21)
Molecular aspects of complement activation (1981) (21)
Synthesis of complement components by synovial membrane. (1992) (21)
Mechanism of Action of Anti-C1-Inhibitor Autoantibodies: Prevention of the Formation of Stable C1s-C1-inh Complexes (1998) (20)
Some aspects in the quantitation of inflammation in joints of patients suffering from rheumatoid arthritis. (1970) (20)
A secondary C1s interaction site on C1‐inhibitor is essential for formation of a stable enzyme‐inhibitor complex (1997) (20)
Familial properdin deficiency associated with chronic discoid lupus erythematosus. (1989) (20)
Alternative pathway complement activation in rheumatoid arthritis. (1980) (20)
Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus. (1979) (20)
Biosynthesis of complement components. (1982) (19)
Sjögren's syndrome in psoriatic arthritis, ankylosing spondylitis and Reiter's syndrome. (1971) (19)
Lymphocytic sialadenitis in the buccal mucosa, in Sjögren's disease, rheumatoid arthritis and other arthritides. A clinical and laboratory study. (1968) (19)
The complement system in sepsis and trauma. (1985) (18)
Complement metabolism in the seronegative arthritides. (1974) (18)
Regulation of hepatic synthesis of C3 and C4 during the acute‐phase response in the rat (1989) (17)
Control of complement activation in membranous and membranoproliferative glomerulonephritis. (1980) (17)
Circulating immune complexes associated with decreased complement-mediated inhibition of immune precipitation in sera from patients with bacterial endocarditis. (1986) (17)
Effect of histamine on monocyte complement production. II. Modulation of protein secretion, degradation and synthesis. (1980) (16)
Penicillin allergy in rheumatoid arthritis. With special reference to Sjogren's syndrome. (1969) (16)
Regulation of C1-inhibitor synthesis by interferons and other agents. (1989) (15)
A single base deletion from the C1-inhibitor gene causes type I hereditary angio-oedema. (1992) (15)
Radioisotope study of small joint inflammation in rheumatoid arthritis. (1971) (15)
Regional assignment of the human C1-inhibitor gene to 11q11–q13.1 (1990) (15)
Fatal Subaxial Dislocation of Cervical Spine in Rheumatoid Arthritis (1968) (15)
Control of immune complexes by the classical pathway. (1989) (14)
Prevention of immune precipitation by purified components of the alternative pathway. (1985) (14)
Autoantibodies in childhood connective tissue diseases and in normal children. (1975) (14)
Purification of a plasma protein that inhibits complement-mediated prevention of immune precipitation. (1988) (13)
A point mutation in the C1-inhibitor gene causes type I hereditary angiooedema. (1993) (13)
Type II hereditary angio-oedema associated with two mutations in one allele of the C1-inhibitor gene around the reactive-site coding region. (1992) (13)
Quantitation of human C4A and C4B, in serum and plasma by enzyme-linked immunoadsorbent assay (2004) (13)
Biosynthesis of complement components by cultured rat hepatocytes. (1985) (12)
Restriction fragment length polymorphism analysis of the C1‐inhibitor gene in hereditary C1‐inhibitor deficiency (1991) (12)
Measurement of complement activation in clinical practice. (1989) (12)
Clinical Significance of Native DNA Antibodies in Systemic Lupus Erythematosus and other Connective Tissue Diseases (1974) (12)
Experimental induction of immune sialadenitis in guinea-pigs using different adjuvants. (1974) (12)
Role of the distal hinge region of C1‐inhibitor in the regulation of C1s activity (1997) (12)
Inhibition of complement-mediated solubilization of antigen-antibody complexes by sera from patients with rheumatoid arthritis. (1983) (12)
The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation. (1988) (12)
The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: correlation with the prevention of immune precipitation. (1990) (11)
EVALUATION OF THE NATIVE DNA‐BINDING ASSAY FOR DNA ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS AND OTHER CONNECTIVE TISSUE DISEASES (1974) (10)
Effect of Anti-inflammatory Drug Therapy on Clearance of 133Xe from Knee Joints of Patients with Rheumatoid Arthritis (1969) (10)
Mechanism of action of an inhibitor of complement-mediated prevention of immune precipitation. (1990) (10)
The sequence of a cDNA encoding functional murine C1-inhibitor protein. (1997) (10)
Cyclic AMP-mediated modulation of the production of the second component of human complement by monocytes. (1981) (10)
THE INTERACTION BETWEEN HUMAN SERUM AMYLOID P COMPONENT [SAP] AND FIXED COMPLEMENT (1982) (10)
Studies of the action of some anti-inflammatory drugs on complement mediated immune haemolysis. (1975) (9)
Sjogren's syndrome: its clinical manifestations and associations. (1972) (9)
Measurement of complement activation products in patients with chronic rheumatic diseases (2005) (9)
Complement, antigen-antibody complexes and immune complex disease. (1985) (9)
Hereditary Angio-Oedema: Its Pathogenesis and Management (1980) (8)
Dissociation of primary antigen-antibody bonds is essential for complement mediated solubilization of immune precipitates. (1992) (8)
Characterisation of nucleotide sequence variants and disease-specific mutations involving the 3' end of the C1-inhibitor gene in hereditary angio-oedema. (1995) (8)
The plasma protein which inhibits complement-mediated prevention of immune precipitation is an Fc binding protein. (1989) (8)
Effect of synovectomy on the clearance of radioactive xenon (133Xe) from the knee joint of patients with rheumatoid arthritis. (1970) (8)
Immunohistochemical localization of a plasma protein (glycoprotein 60) which inhibits complement-mediated prevention of immune precipitation. (1990) (8)
In vitro studies on the phagocytosis of Staphylococcus aureus by peritoneal macrophages of New Zealand mice. (1973) (7)
Computer-assisted diagnosis in keratoconjunctivitis sicca. (1971) (7)
Enhancement of monocyte complement component synthesis by antigen--antibody complexes. (1981) (7)
Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study. (1979) (7)
Effect of Glyvenol (CIBA) on pain and on capillary resistance in rheumatoid arthritis. (1969) (7)
Recent advances in Sjogren's syndrome. (1971) (7)
Modulation of monocyte complement synthesis by lymphocytes and lymphocyte-conditioned media. (1989) (7)
Serum-treated antigen-antibody complexes inhibit the production of C2 and factor B by mononuclear phagocytes. (1983) (6)
Modulation of the alternative complement pathway in patients with Gram‐negative bacteraemia (1980) (6)
Modulation of the properdin amplification loop in membranoproliferative and other forms of glomerulonephritis. (1979) (6)
Purification and characterization of RHP (factor H) and study of its interactions with the first component of complement. (1992) (6)
Complement levels in serum and bile in patients with extra-hepatic biliary tract obstruction. (1984) (5)
An RNA splice site mutation in the C1-inhibitor gene causes type I hereditary angio-oedema (1991) (5)
The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence (2004) (5)
The lysine-vasopressin test: an evaluation of two methods of administration in non-corticosteroid-treated and corticosteroid-treated patients with rheumatoid arthritis. (1970) (5)
Phagocytosis inhibits the production of C2 by human monocytes. (1983) (5)
A comparison of the effects of heat-aggregated and chemically cross-linked IgG on monocyte C2 production. (1983) (5)
C3bINA Accelerator: A Serum Cofactor for C3b Inactivator Necessary for the Full Expression of Its Activity (1976) (5)
Role of C3 in the control of monocyte C2 production. (1984) (5)
Sjögren's syndrome. (1972) (5)
Anaphylatoxins inhibit C2 production. (1983) (4)
Evidence for glomerular modulation of complement activation. (1979) (4)
Clinical Trial of Lincomycin Hydrochloride in Reiter's Disease (1969) (4)
Cyclic AMP mediated modulation of complement protein production. (1982) (4)
Antimycobacterial hsp65 and rheumatoid factor titres in a population of normal twins: evidence of genetic control of rheumatoid factor (1995) (4)
Modulation of C2 biosynthesis by antigen-antibody complexes. (1982) (4)
The Clinical Significance of the Antinuclear Antibody Test as a Screening Procedure for DNA Antibodies in SLE (1980) (4)
Measurement of synovial blood flow in normal and diseased joints. (1969) (4)
The relative roles of genetic and environmental factors in the regulation of erythrocyte C3b receptor (ECR1) numbers in normal individuals. (1987) (4)
Cellular immune mechanisms in rheumatoid arthritis and Sjögren's syndrome. (1971) (3)
Human complement factor B: functional properties of a recombinant zymogen of the alternative activation pathway convertase. (1993) (3)
Phagocytosis of Colloidal Carbon by the Fixed Tissue and Peritoneal Macrophages of New Zealand Mice (1972) (3)
The role of ion channels and protein kinase C activation in the stimulation of complement protein synthesis. (1987) (3)
Synthesis and secretion of complement components by mononuclear phagocytes (1985) (3)
The complement system and inflammation (1995) (3)
Complement and related clinical disorders. (1989) (3)
Therapeutic Immunosuppression (2001) (3)
Articular scan in patients with rheumatoid arthritis: a possible method of quantitating joint inflammation usine radio-technetium. (1969) (3)
Clinical aspects of auto-immunity. (1969) (3)
Adaptation of Enzyme Labelled Immunoassay (ELISA) for Measurement of Biosynthesis of Human and Rat Complement Components (1988) (3)
Conjugal prevalence of rheumatoid arthritis, rheumatoid factor and other autoantibodies in rheumatoid arthritis. (1968) (3)
Regional chromosomal assignment of genes encoding the α and β subunits of human complement protein C8 to 1p32 (1992) (3)
Requirement for cations in the stimulation of C2 synthesis by human monocytes. (1985) (3)
Clinico-pharmacological studies on depot tetracosactrin in patients with rheumatoid arthritis (1970) (2)
Control of monocyte C2 production by cyclic AMP. (1983) (2)
Comparison of the Adrenocorticotrophic Activities of Two Synthetic Polypeptides: Synacthen and DW 75* (1968) (2)
Complement deficiency syndromes and bacterial infections. (1983) (2)
C1-inhibitor synthesis by monocytes of patients with C1-inhibitor deficiency (1987) (2)
Liver palms in rheumatoid arthritis. (1969) (2)
Complement and the Mononuclear Phagocyte System (1993) (2)
Follow-up studies on synovectomy of the knee in rheumatoid arthritis. (1970) (2)
Synovectomy of the knee in rheumatoid arthritis: critical appraisal based on a long-term follow-up of 145 patients. (1973) (1)
Effect of interferon-y on complement gene expression in different cell types (2005) (1)
Immunohistochemical and functional studies of glycoprotein 60 (gp60) in platelets (2004) (1)
Conjugal prevalence of rheumatoid arthritis, rheumatoid factor, and other autoantibodies in rheumatoid arthritis. (1969) (1)
Sympathetic control of synovial blood vessels. (1970) (1)
Hypocomplementaemia and Disease (1978) (1)
The incidence of antinuclear antibodies in relation to drug therapy in psychiatric patients [proceedings]. (1975) (1)
Assessment of a test of adrenocortical function using beta1-25 corticotrophin. (1969) (1)
Use of antisera to the isolated alpha and beta subunits of C3 as probes to study functional sites present on particle-bound C3b but absent on native soluble forms of C3. (1988) (1)
Inhibition of C1q binding to antigen-antibody complexes by a factor in rheumatoid arthritis serum (2004) (1)
The effect of isoprenaline and noradrenaline on an indirect measure of synovial blood flow in dogs. (1970) (1)
Comparative study of endralazine and hydralazine for the treatment of hypertension uncontrolled by a beta-blocker and diuretic. (1986) (1)
Aspects ofSjogren's Syndrome (1971) (1)
KpnI RFLP in the 3' flanking region of the C1 inhibitor gene. (1989) (1)
Immunological Mechanisms in the Pathogenesis of Systemic Lupus Erythematosus (1970) (1)
An inhibitor of complement-mediated prevention of immune precipitation in rheumatoid arthritis — relationship to disease activity and systemic manifestations (2004) (1)
C1-inhibitor gene nucleotide insertion causes type II hereditary angio-oedema (1993) (1)
Regional chromosomal assignment of genes encoding the alpha and beta subunits of human complement protein C8 to 1p32. (1992) (1)
Book Review: New Books: Diagnostic Immunology and Serology: A Clinician's Guide (1980) (0)
Liver disease inrheumatoid arthritis and Sj0gren's syndrome Prospective studyusing biochemical andserological markers ofhepatic dysfunction (1975) (0)
Theplasmaprotein whichinhibits complement-mediated prevention ofimmuneprecipitation isan Fcbinding protein (1989) (0)
Histology ofthelacrimal glandin keratoconjunctiv itis (1972) (0)
Acquired C1 esterase inhibitor deficiency (1988) (0)
Observations on the clinical outcome and recovery of hypothalamo-pituitary-adrenal axis function after complete withdrawal of long-term corticosteroid therapy in patients with rheumatoid arthritis. (1970) (0)
Clearance of dna from blood in new zealand mice (1972) (0)
Clinical Approach to Immunotoxicology and Autoimmunity (1997) (0)
Anti Mycobacterial HSP 65 and Rheumatoid Factor Titres in a Population of Normal Twins (1994) (0)
Proceedings: Antigen catabolism in New Zealand and other strains of mice. (1974) (0)
Nicotinic cholinergic receptors on human and guinea pig mononuclear phagocytes modulate C2 synthesis (1982) (0)
Synthesis ofclassical pathwaycomplement componentsbychondrocytes (1996) (0)
[Sjögren's syndrome (detailed description)]. (1976) (0)
Immunological studies of the connective tissue diseases using New Zealand mice as a laboratory model (1973) (0)
Cancer Immunology (2001) (0)
Observations on thevalue ofpotentanalgesics andplacebos (1973) (0)
Clearance of deoxyribonucleic acid from blood in New Zealand mice. (1972) (0)
AbstractModulation of C2 and factor B(B) synthesis by Fc and C3b receptors (1982) (0)
Studies on thyroid function in the mouse: interstrain differences in thyroxine secretion rates and organ content of thyroxine. (1973) (0)
Recent Developments in Prophylactic Immunization (2011) (0)
Monocyte C1‐inhibitor synthesis in patients with C1‐inhibitor deficiency (1989) (0)
Modulation of classifical pathway complement activation in rheumatic diseases (1984) (0)
Immunobiology of the Complement System: An Introduction for Research and Clinical Medicine (1987) (0)
Catabolism of bovine gamma globulin in New Zealand mice. (1972) (0)
Book Review / News Item (1983) (0)
Laboratory investigation of immunodeficiency and autoimmunity in humans (1995) (0)
A simple technique for measuring thyroxine secretion rate in the mouse. (1973) (0)
Effect of anti-inflammatory drug therapy on clearance of 133-Xe from knee joints of patients with rheumatoid arthritis. (1969) (0)
Inhibition of immune precipitation in rheumatic disease. A clinical and laboratory study. (1984) (0)
Rheumatic Diseases Table I Clinicalfeatures of patients studied Sex Clinical group Ankylosing spondylitis Reiter ' s disease Still ' s disease Psoriatic arthritis (0)
Assessment of clinical methods of evaluation and isotope techniques in analgesic trials in rheumatoid arthritis. (1970) (0)
Inhibition of complement-mediated solubilisation of antigen-antibody complexes by serum factor(s) in patients with various connective tissue diseases. (1986) (0)

This paper list is powered by the following services:

Other Resources About K. Birgitta Whaley

en.wikipedia.org

What Schools Are Affiliated With K. Birgitta Whaley?

K. Birgitta Whaley is affiliated with the following schools:

K. Birgitta Whaley's Academic­Influence.com Rankings